Nephros Inc. (NEPH) Eyes Upside: Underpriced, European Expansion & Regulatory Boosts
Nephros Inc. (NEPH) offers an underpriced entry into the growing renal therapeutics sector, with a promising hemodiafiltration technology and European expansion plans that could boost future upside.
2 minutes to read